Biophore India Pharmaceuticals Private Limited Vs DCIT (ITAT Hyderabad)
Case ke facts
Biophore India Pharmaceuticals ko department ne Section 263 lagaya aur Rs. 32.50 lakh ka Section 14A disallowance bola jabki koi exempt income nahi thi.
Mudda (Issue)
Kya Section 263 ka revision chal sakta hai jab exempt income hi nahi thi?
Faisla (Held)
ITAT Hyderabad ne Section 263 revision radd kar diya. Bola ki 2022 ka amendment prospective hai aur bina exempt income ke Section 14A nahi lagta.
Practical takeaway
Exempt income na ho to AO Section 14A disallowance par Section 263 lagaye to usko challenge kar sakte ho.
Original report: taxguru.in
Aapke case mein bhi aisa hi mudda hai?
CGA ki team notice, appeal aur department proceedings mein kaam karti hai. Documents ke saath baat kariye.
WhatsApp par poochiyeIncome tax notice ka jawabAur Income Tax faisle
- Aditya Plastic Vs ITO (ITAT Rajkot)ITAT Rajkot · Section 151, Section 271(1)(b)
- ITO Vs NSL Nagapatnam Power Ventures Private Limited (ITAT Hyderabad)ITAT Hyderabad · Section 14A
- Sanjay Kalsi Vs Central Circle-04 (ITAT Delhi)ITAT Delhi · Section 271DA
- Sharda Jain Vs PCIT-1 (Chhattisgarh High Court)Chhattisgarh High Court · Section 148A(d), Section 148
- AEON Formulations Pvt. Ltd. Vs ITO (ITAT Chennai)ITAT Chennai
- DCIT Vs Reliance Industries Limited (Supreme Court of India)Supreme Court of India
Yeh summary public report par aadhaarit general jaankari hai, legal advice nahi. Poora faisla padhne ke liye original source dekhiye. Published on cgaindia.com: 2026-10-17.